Inhibiting CD39, an ecto-enzyme converting extracellular ATP to AMP, through antibody activates NLRP3 inflammasomes leading to IL-18 secreting that expands intra-tumor effector CD4+ and CD8+ T cells [210]. Here, IL18 is linked to neoplasm.